KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Other Accumulated Expenses: 2015-2024

  • Nu Skin Enterprises' Other Accumulated Expenses rose 26.72% to $35.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $35.6 million, marking a year-over-year increase of 26.72%. This contributed to the annual value of $35.6 million for FY2024, which is 26.72% up from last year.
  • Nu Skin Enterprises' Other Accumulated Expenses amounted to $35.6 million in Q4 2024, which was up 26.72% from $28.1 million recorded in Q4 2023.
  • Nu Skin Enterprises' 5-year Other Accumulated Expenses high stood at $45.0 million for Q4 2020, and its period low was $28.1 million during Q4 2023.
  • Its 3-year average for Other Accumulated Expenses is $32.9 million, with a median of $34.9 million in 2022.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 51.80% in 2020, then tumbled by 30.84% in 2021.
  • Over the past 5 years, Nu Skin Enterprises' Other Accumulated Expenses (Quarterly) stood at $45.0 million in 2020, then plummeted by 30.84% to $31.1 million in 2021, then climbed by 12.16% to $34.9 million in 2022, then fell by 19.45% to $28.1 million in 2023, then increased by 26.72% to $35.6 million in 2024.
  • Its last three reported values are $35.6 million in Q4 2024, $28.1 million for Q4 2023, and $34.9 million during Q4 2022.